- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Segment 10 - Evidence-Based Medicine in the "Real-World" Healthcare Setting
The panelists continued to discuss evidence-based medicine, as well as the incentives there might be to examine emerging and existing therapies or drugs.
The panelists continued to discuss evidence-based medicine, as well as the incentives there might be to examine emerging and existing therapies or drugs.
Dr Yu revisited the difference between findings that are presented in studies, as they compare to finding in real-world settings. He said assumptions about “best regimens” should be tested to determine patient response. Drugs and patient outcomes should be continually monitored, even after gaining FDA approval.
Dr Marlin said pathway programs can motivate drug or therapy manufacturers to expand development of evidence-based medicines. She thought that the current shift in treatment decision-making will incentivize developers to invest in evidence-based medicine.
Dr Nabhan said literature focuses too strongly on efficacy. Certain measures, such as hospitalizations, cannot be observed in small clinical trials.
Dr Tischler agreed, saying that many decisions should be made based on real-world setting data and observations.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Balancing Innovation and Equity in Oncology Value-Based Care: Panel Discussions
January 27th 2025Discussions also delved into the complexities of value-based oncology care, the growing role of real-world data, and strategies to improve access to care in hematology. Across all sessions, a common theme emerged: the need to balance innovation with patient-centered, equitable, and sustainable care models.
Read More
